AXSM
Axsome Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$156.08
+1.96 ▲ +1.27%
🌙 3월 13일 7:39 PM ET (한국 3/14 08:39)
$155.99
-0.09 ▼ -0.06%
| Index | RUT | P/E | - | EPS (ttm) | -3.69 | Insider Own | 16.34% | Shs Outstand | 0.05B | Perf Week | -3.85% |
| Market Cap | 7.98B | Forward P/E | 25.39 | EPS next Y | 854.17% | Insider Trans | -7.7% | Shs Float | 0.04B | Perf Month | -16.18% |
| Enterprise Value | 7.88B | PEG | - | EPS next Q | -0.79 | Inst Own | 74.09% | Short Float | 6.06% | Perf Quarter | 4.57% |
| Income | -0.18B | P/S | 12.5 | EPS this Y | 77.85% | Inst Trans | 0.08% | Short Ratio | 3.87 | Perf Half Y | 26.94% |
| Sales | 0.64B | P/B | 89.95 | EPS next 5Y | - | ROA | -29.11% | Short Interest | 2.59M | Perf YTD | -14.54% |
| Book/sh | 1.74 | P/C | 24.72 | EPS past 3/5Y | 7.17% -5.89% | ROE | -252.11% | 52W High | -18.5% ($191.50) | Perf Year | 28.3% |
| Cash/sh | 6.31 | P/FCF | - | Sales past 3/5Y | 133.68% - | ROIC | -78.47% | 52W Low | 79.42% ($86.99) | Perf 3Y | 156.46% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 38.38% | Gross Margin | 91.16% | Volatility(W/M) | 3.27% 3.27% | Perf 5Y | 134.74% |
| Dividend TTM | - | EV/Sales | 12.34 | Sales Y/Y TTM | 65.55% | Oper. Margin | -26.51% | ATR (14) | 5.53 | Perf 10Y | 2085.99% |
| Dividend Ex-Date | - | Quick Ratio | 1.48 | EPS Q/Q | 63.45% | Profit Margin | -28.69% | RSI (14) | 33.24 | Recom | 1.14 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.55 | Sales Q/Q | 65.03% | SMA20 | -7.48% ($168.7) | Beta | 0.51 | Target Price | $223.65 |
| Payout | - | Debt/Eq | 2.47 | Earnings | 2000000 | SMA50 | -11.3% ($175.96) | Rel Volume | 1.29 | Prev Close | $154.12 |
| Employees | 925 | LT Debt/Eq | 1.64 | EPS/Sales Surpr. | 19.3% 0.69% | SMA200 | 14.82% ($135.93) | Avg Volume(3M) | 0.67M | Price | $156.08 |
| IPO | 2015/11/19 | Option/Short | Yes/Yes | Trades | 10568 | Volume | 862,767 | Change | 1.27% |
뉴스 로딩 중...